Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies

Author: Wieder Robert   Novick Steven C.   Hollis Bruce W.   Bryan Margarette   Chanel Suzanne M.   Owusu Kate   Camastra Danielle   Saunders Tracie   Pliner Lillian   Harrison Jonathan   Bonate Peter   Williams Tom   Soignet Steven  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.21, Iss.4, 2003-11, pp. : 445-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content